Metabolism of tellurium, antimony and germanium simultaneously administered to rats

Journal of Toxicological Sciences

Volumn 34, Issue 3, 2009, Pages 295-303

  Kobayashi, Akihiro ^a   Ogra, Yasumitsu ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antimony; Germanium; Hemoglobin; ICP MS; Speciation; Tellurium

Indexed keywords

ANTIMONITE; ANTIMONY; GERMANIUM; GERMANIUM DIOXIDE; TELLURITE; TELLURIUM; TRIMETHYLTELLURONIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE; MALE; METABOLITE; METAL METABOLISM; NONHUMAN; RAT; URINALYSIS;

RATTUS;

EID: 67649238664     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.295     Document Type: Article

References (26)

1. DeMeio, R.H. and Jetter, W.W. (1948): Tellurium. The toxicity of ingested tellurium dioxide for rats. J. md. Hyg. Toxicol., 30, 53-58.
2. Frei, G.M., Kremer, M., Hanschmann, K.M., Krause, S., Albeck, M., Sredni, B. and Schnierle, B.S. (2008): Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101. Br. J. Dermatol., 158, 578-586.
3. Hansen, H.R. and Pergantis, S.A. (2006): Investigating the formation of an Sb(v)-citrate complex by HPLC-ICP-MS and HPLCES-MS(/MS). J. Anal. At. Spectrom., 21, 1240-1248.
4. Haraguchi, H. (2004): Metallomics as integrated biometal science. J. Anal. At. Spectrom., 19, 5-14.
5. Hayakawa, T., Kobayashi, Y., Cui, X. and Hirano, S. (2005): A new metabolic pathway of arsenite: Arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol., 79, 183-191.
6. Hirayama, C., Suzuki, H., Ito, M., Okumura, M. and Oda, T. (2003): Propagermanium: A nonspecific immune modulator for chronic hepatitis B. J. Gastroenterol., 38, 525-532. (Pubitemid 36857382)
7. Krachler, M. and Emons, H. (2001): Urinary antimony speciation by HPLC-ICP-MS. J. Anal. At. Spectrom., 16, 20-25.
8. Lu, M., Wang, H., Li, X.F., Lu, X., Cullen, W.R., Arnold, L.L., Cohen, S.M. and Le, X.C. (2004): Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol., 17, 1733-1742.
9. McCallum, R.I. (2005): Occupational exposure to antimony compounds. J. Environ. Monit., 7, 1245-1250.
10. Mitchell, R.D., Ayala-Fierro, F. and Carter, D.E. (2000): Systemic indicators of inorganic arsenic toxicity in four animal species. J. Toxicol. Environ. Health A, 59, 119-134.
11. Naranmandura, H., Suzuki, N. and Suzuki, K.T. (2006): Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol., 19, 1010-1018.
12. Naranmandura, H., Ibata, K. and Suzuki, K.T. (2007): Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells. Chem. Res. Toxicol., 20, 1120-1125.
13. Ogra, Y., Ishiwata, K., Takayama, H., Aimi, N. and Suzuki, K.T. (2002): Identification of a novel selenium metabolite, Se-methyl-N- acetylselenohexosamine, in rat urine by high-performance liquid chromatography-inductively coupled plasma mass spectrometry and -electrospray ionization tandem mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sd., 767, 301-312.
14. Ogra, Y., Kobayashi, R., Ishiwata, K. and Suzuki, K.T. (2007): Identification of urinary tellurium metabolite in rats administered sodium tellurite. J. Anal. At. Spectrom., 22, 153-157.
15. Ogra, Y., Kobayashi, R., Ishiwata, K. and Suzuki, K.T. (2008): Comparison of distribution and metabolism between tellurium and selenium in rats. J. Inorg. Biochem., 102, 1507-15 13.
16. Poon, R., Chu, I., Lecavalier, P., Valli, V.E., Foster, W., Gupta, S. and Thomas, B. (1998): Effects of antimony on rats following 90-day exposure via drinking water. Food Chem. Toxicol., 36, 21-35.
17. Santos, D.O., Coutinho, C.E.R., Madeira, M.F., Bottino, C.G., Vieira, R.T., Nascimento, S.B., Bernardino, A., Bourguignon, S.C., Corte-Real, S., Pinho, R.T., Rodrigues, C.R. and Castro, H.C. (2008): Leishmaniasis treatment - A challenge that remains: A review. Parasitol. Res., 103, 1-10.
18. Sharma, P., Perez, D., Cabrera, A., Rosas, N. and Arias, J.L. (2008): Perspectives of antimony compounds in oncology. Acts Pharmacol. Sin., 29, 881-890.
19. Suzuki, K.T., Mandal, B,K. and Ogra, Y. (2002): Speciation of arsenic in body fluids. Talanta, 58, 111-119. (Pubitemid 34857387)
20. Szpunar, J. (2005): Advances in analytical methodology for bioinorganic speciation analysis: Metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst, 130, 442-465. (Pubitemid 40523241)
21. Taylor, A. (1996): Biochemistry of tellurium. Biol. Trace Elem. Res., 55, 231-239.
22. Vahter, M. (2000): Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett., 112-113, 209-217.
23. Vanholder, R., Cornelis, R., Dhondt, A. and Lameire, N. (2002): The role of trace elements in uraemic toxicity. Nephrol. Dial. Transplant., 17, 2-8.
24. Wang, T.C., Jan, K.Y., Wang, A.S.S. and Gurr, J.R. (2007): Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. Fundam. Mol. Mech. Mutagen., 615, 75-86.
25. Yamada, N., Kojima, R., Uno, M., Akiyama, T., Kitaura, H., Narumi, K. and Nishiuchi, K. (2002): Phase change material for use in rewritable dual-layer optical disk. Proc. SPIE-Int. Soc. Opt. Eng., 4342, 55-63.
26. Yamasoba, T., Someya, S., Yamada, C., Weindruch, R., Prolla, T.A. and Tanokura, M. (2007): Role of mitochondrial dysfunction and mitochondrial DNA mutations in age-related hearing loss. Hear. Res., 226, 185-193.